Welcome to Malaysia Association for Cell Therapy  
MACT 5th Scientific Meeting
Home : MEETINGS / EVENTS : MACT 5th Scientific Meeting

D7-3-1 Block D7, Pusat Perdagangan Dana 1,
Jalan PJU 1A/46, PJU 1A, 47301 Petaling Jaya,
Selangor Darul Ehsan

MACT 5th Scientific Meeting

Date: 20th September  (Saturday) 2014
Venue: Level 3A, Connexion @ Nexus, Jalan Kerinchi, Bangsar South Kuala Lumpur (4.30 pm to 8.30 pm )


All attendees must register prior to attending the Scientific Meeting. Seating is limited, and preference will be given to those who registered in advance online. The social highlight of the meeting will be a Dinner hosted by HITV Laboratory Sdn Bhd.  Please note that members who want to join the dinner must register early. Members with a max of 2 participants from each company under the Full Membership category and max of 1 participant for Associate Membership will be sponsored for the networking dinner. If the number of participants are more than 2 (for associate membership, more than 1), please contact the Secretariat for further details, to cover expenses, a nominal registration fee will be charged. Seats are limited. Please do register early to avoid any disappointment. 


Tentative program:


Scientific Meeting Program 20th Sept 2014



EXCO Meeting (only for EXCO members)



Registration and Tea break



Welcome Address by the President, Dr Lim Teck Onn



Speaker :

Dr. Konstantinos I. Papadopoulos, MD, PhD

“The use of PBSC in Osteoarthritis”

Stemlife Berhad




Professor Dr. S. Fadilah Binti Abdul Wahid, Senior Consultant Hematologist, Head of Hematology Unit, Head of Cell Therapy Centre, Pusat Perubatan Universiti Kebangsaan Malaysia on

" A Phase II Study With Intratumoral Injection Of Autologous DC & ATC Combined With RT In Patients With Relapsed and Refractory B Cell Lymphoma"

(Invitation extended on behalf by HITV Laboratory Sdn Bhd)



Speaker :

Dr Kenichiro Hasumi"An Update On Cell-Based Anti-Cancer Treatment"-

Clinical Summary Of Advanced Malignancies Treated With Dendritic Cell Based Vaccine Therapy Combined With Conventional Therapy

ICVS Tokyo Clinic, Professor, Jefferson Medical College, Thomas Jefferson School of Medicine

(Invitation extended on behalf by HITV Laboratory Sdn Bhd)



Dinner co-sponsored by HITV Laboratory Sdn Bhd



BIOGRAPHY of Dr. Konstantinos Papadopoulos, MD, PhD

Dr. Konstantinos Papadopoulos, MD, PhD is a Greek national fluent in several languages. He has held Specialist, Teaching, and Research Positions at the Department of Endocrinology and Diabetes, University of Lund, University Hospital, Malmo, Sweden, at the Department of Internal Medicine, Liverpool, and Fairfield Hospitals, and as Clinical Tutor in Medicine for the overseas doctors training programme in N.S.W., Australia. Furthermore, he has held a Lectureship in Endocrinology at the University of Alexandroupolis, Greece. He has been the Associate Director International Medical Services for Asia/Pacific at Organon International. He has published several papers in the field of Endocrinology, has performed referee assignments for several Medical Journals and has been an invited speaker and chairman at numerous occasions in the fields of Endocrinology/Diabetology, Infertility and Reproductive Endocrinology, HRT, Anesthesiology, Depression, Stem Cell Biology, Genetics and Nutrition. His latest peer reviewed publication is on the use of a child’s own cord blood in Cerebral Palsy and the use of Own Adult Stem Cells in early Knee Osteoarthritis.

At present, he is the CMRD of THAI StemLife, an international biotechnology company specializing in umbilical cord blood and peripheral blood adult stem cell storage and R&D as well as Predictive Genetic Testing located in Bangkok, Thailand.

Moreover, Dr Papadopoulos is an Expert in Genetic Preventive Medical Programs, Longevity and Lifestyle Planning, and Medical Fitness. He holds a Level 3 Gym Jones Certificate.


BIOGRAPHY of Dr. Hasumi

Dr. Kenichiro Hasumi is a physician, specialized in cancer immunotherapy and terminal care. He is also a researcher and visionary, focused on the development of cancer immunotherapy, especially vaccines and improved clinical treatments to achieve better patient outcomes with a higher quality of life. Currently, Dr. Hasumi holds a number of patents on a therapeutic cancer vaccine and adjuvant in Japan, the United States, EU, Singapore, Russia, India and Mexico. Most of the patents have been applied to his current clinical practices. In 1999, Dr. Hasumi established the Hasumi International Research Foundation (HIRF) in the United States. The primary purpose of HIRF is to conduct and support scientific research in connection with finding a cure for various forms of cancer, particularly with the use of immunotherapy. Its mission also is to develop a highly sophisticated database and networking system for the collection and dissemination of valuable data from cancer research and treatment throughout the world. HIRF has also been sponsoring the International Cancer Vaccine Symposium since 2001. Dr. Hasumi also is chairman of Hasumi Group, including HIRF, Shukokai Inc, ICVS Tokyo Clinic, BSL-48 Clinic, Hijirigaoka Hospital, Hijiri-no-Sato Elderly Health Care Facility, and the Electro-Chemical and Cancer Institute.



If you need additional information regarding the scientific meeting, please contact MACT Secretariat, via email at mact2012@gmail.com or by telephone at 03- 78426322. Please note that this program is TENTATIVE and subject to change without notice. Visit www.mact.org.my for details and updates 

Terms and conditions:

Note: Subject to capacity, registration may close prior to the conference. Please register early.

  • Fees are non-refundable. Substitution are allowed at no charge. All notes and handout are not provided. Please REGISTER before 5th September 
  • There will be no Certificate of Attendance
  • MACT reserves the right to cancel any workshop/ conference or meetings at our discretion. Reasons for cancellation might include (but are not limited to) where number are insufficient or a trainer / speaker is indisposed or unable to confirm the venue.
  • MACT expressly forbids the right to reproduce any part of our workshop / meetings in any form (e.g. on the internet, DVDs, photographs etc). Anyone suspected of filming or photographing the session for any purpose of publication, without the written permission of the MACT, may be asked to leave the session
  • Participants bringing along valuables and personal property do so at their own risk and are responsible for their safety. MACT cannot be held liable for loss or damage to personal items.
  • All travel and accommodation arrangements are the responsibility of participants


Member Email :

Password :

Image Verification :  
  Change image

Forgot Password?